17 results on '"Hong, Huiqi"'
Search Results
2. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer
3. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis
4. Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression
5. Author Correction: Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing
6. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development
7. Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing
8. Chrysophanol attenuated isoproterenol‐induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
9. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway
10. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer
11. SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction
12. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer
13. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy
14. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer
15. An RNA editing/binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer
16. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy
17. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.